Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs


Caduceus symbol as a pair of scales for weighing

Afro-European Partnerships in Health: Accelerating Better Efficiency of Health Spending

In the wake of the COVID-19 crisis, many sub-Saharan African countries will face serious economic crises and shrinking public spending. If countries are unable to spend more, they need to spend better. Europe has leading expertise in building institutions for priority-setting in health, making it an obvious potential source for collaboration with the Global South.

An image of the spread of COVID-19 around the world

We Must Stop Flying Blind: Building on Existing Systems In Low- and Middle-Income Countries To Improve the COVID-19 Response

COVID- 19 has brought a sense of urgency to decision-making that typically would have taken many months and years of deliberation. Central to this uncertainty is the glaring lack of knowledge on just how big the burden of COVID-19 truly is. The pandemic has highlighted concerning gaps in data and weaknesses in surveillance systems that have long hampered public health systems globally, especially in low- and middle- income countries (LMIC).

A close-up of some pills

Healthcare Technologies and COVID-19: Speed is Not Always a Good Thing

With a focus on tests, treatments, and a vaccine, we take a look at the emerging global clinical and economic evidence-base underpinning some of these technologies, the mechanisms (mostly global) for financing these commodities, and, finally, the decision-making processes for selecting technologies. This includes identifying the right subpopulations and negotiating a cost-effective tiered price across countries and regions.

A figure showing that the patients with the most critical cases are a small percentage but their case takes most of the resources required.

Strengthening the Basics: Approaches to COVID-19 Care in Low-Resource Settings

This blog focuses on hospital treatment for COVID-19 patients in low-resource-settings, considering what we know about the spectrum of COVID-19 illness and what this tells us about where resources might best be focused in low-resource-settings. As elsewhere, decision makers, global and local, must prioritise resourcing and capacity development for the ward-level care and simple oxygen therapy that most hospitalised COVID-19 patients will need—not the high-end clinical care that may well be impossible to scale-up in time in countries with limited resources.